{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6bv3.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10066","date":"2024-06-10T16:00:00.000Z","role":"Approver"},{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10066","date":"2024-07-02T15:28:35.696Z","role":"Publisher"}],"curationReasons":{"id":"cg:RecurationTiming"},"evidence":[{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:2c194e37-ab3c-43ee-bf5c-5598cbad5d71","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:184244b6-a4ee-4996-98c2-60b7ebb453b5","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"In a kidney biopsy from a control individual stained for MAPKBP1 and acetylated tubulin to label cilia,  Macia et al. found a diffuse granular distribution of MAPKBP1  in the cytoplasm of tubular epithelial cells as well as in epithelial cells from the Bowman capsule. MAPKBP1 was not found to be expressed in interstitial cells. MAPKBP1 was also expressed in cells in glomeruli where it was also found in the nucleus in some cells. MAPKBP1 was not detected in cilia.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/28089251","type":"dc:BibliographicResource","dc:abstract":"Nephronophthisis (NPH), an autosomal-recessive tubulointerstitial nephritis, is the most common cause of hereditary end-stage renal disease in the first three decades of life. Since most NPH gene products (NPHP) function at the primary cilium, NPH is classified as a ciliopathy. We identified mutations in a candidate gene in eight individuals from five families presenting late-onset NPH with massive renal fibrosis. This gene encodes MAPKBP1, a poorly characterized scaffolding protein for JNK signaling. Immunofluorescence analyses showed that MAPKBP1 is not present at the primary cilium and that fibroblasts from affected individuals did not display ciliogenesis defects, indicating that MAPKBP1 may represent a new family of NPHP not involved in cilia-associated functions. Instead, MAPKBP1 is recruited to mitotic spindle poles (MSPs) during the early phases of mitosis where it colocalizes with its paralog WDR62, which plays a key role at MSP. Detected mutations compromise recruitment of MAPKBP1 to the MSP and/or its interaction with JNK2 or WDR62. Additionally, we show increased DNA damage response signaling in fibroblasts from affected individuals and upon knockdown of Mapkbp1 in murine cell lines, a phenotype previously associated with NPH. In conclusion, we identified mutations in MAPKBP1 as a genetic cause of juvenile or late-onset and cilia-independent NPH.","dc:creator":"Macia MS","dc:date":"2017","dc:title":"Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis."},"rdfs:label":"Expression in Adult Kidney"}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5},{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:a31b6744-5825-4c7c-990f-4372587c6985","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:ca0d2d00-5494-4dc1-95fb-9a9ea0f37121","type":"FunctionalAlteration","dc:description":"shMKBP1.1.1 & shMKBP1.1.3 IMCD3 clones (mutants, with knockdown of MAPKBP1) exhibit increased DNA damage response (DDR) signaling, compared to the control, consistent with the phenotype. Kidney tubules in biopsies from patient BN-23 indicated increased DDR signaling. DDR increase was also observed for mutations in genes including CEP290, SDCCAG8, ZNF423, NEK8, and CEP164 (last two have definitive curations by the the Kidney Cystic & Ciliopathy Disorders Gene Curation Expert Panel).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28089251","rdfs:label":"DNA Damage Response Sigaling"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:bd3b4c51-f0f9-48f8-81dc-49d8f47d4f1b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:bd3b4c51-f0f9-48f8-81dc-49d8f47d4f1b","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":24,"allele":{"id":"cggv:f952ecef-cf29-4793-bcfe-bced28eedbdc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.934C>T (p.Arg312del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391854975"}},"firstTestingMethod":"Homozygosity mapping","phenotypes":["obo:HP_0012595","obo:HP_0000107","obo:HP_0000090","obo:HP_0003774","obo:HP_0030157","obo:HP_0033130"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:d251c875-9a35-4f2f-8b75-d37622679d04_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f952ecef-cf29-4793-bcfe-bced28eedbdc"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/33623699","type":"dc:BibliographicResource","dc:creator":"Al-Hamed MH","dc:date":"2021","dc:title":"Novel pathogenic "}},"rdfs:label":"IV:1"},{"id":"cggv:d251c875-9a35-4f2f-8b75-d37622679d04","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:d251c875-9a35-4f2f-8b75-d37622679d04_variant_evidence_item"}],"strengthScore":1,"dc:description":"This is a truncating mutation, not an in-frame deletion. This variant was downgraded by 1 pt. as there is homozygosity/consanguinity. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a5e523cc-e282-412c-b659-04ef56d24017_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a5e523cc-e282-412c-b659-04ef56d24017","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"allele":{"id":"cggv:e53ee565-d321-49c2-83d6-b3e82140ad51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.3315-2A>G","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391874535"}},"detectionMethod":"Exome sequencing, homozygosity mapping, and NGS of a kidney gene panel done.\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0025576","obo:HP_0000107","obo:HP_0001510","obo:HP_0004719","obo:HP_0002597"],"secondTestingMethod":"Homozygosity mapping","sex":"Female","variant":{"id":"cggv:77ff558e-dd5d-4e5a-ba81-21c9997acc35_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e53ee565-d321-49c2-83d6-b3e82140ad51"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/32505465","type":"dc:BibliographicResource","dc:abstract":"Biallelic mutations in MAPKBP1 were recently associated with late-onset cilia-independent nephronophthisis. MAPKBP1 was found at mitotic spindle poles but could not be detected at primary cilia or centrosomes. Here, by identification and characterization of novel MAPKBP1 variants, we aimed at further investigating its role in health and disease. Genetic analysis was done by exome sequencing, homozygosity mapping, and a targeted kidney gene panel while coimmunoprecipitation was used to explore wild-type and mutant protein-protein interactions. Expression of MAPKBP1 in non-ciliated HeLa and ciliated inner medullary collecting duct cells enabled co-localization studies by fluorescence microscopy. By next generation sequencing, we identified two novel homozygous MAPKBP1 splice-site variants in patients with nephronophthisis-related chronic kidney disease. Splice-site analyses revealed truncation of C-terminal coiled-coil domains and patient-derived deletion constructs lost their ability to homodimerize and heterodimerize with paralogous WDR62. While wild-type MAPKBP1 exhibited centrosomal, basal body, and microtubule association, mutant proteins lost the latter and showed reduced recruitment to cell cycle dependent centriolar structures. Wild-type and mutant proteins had no reciprocal influence upon co-expression excluding dominant negative effects. Thus, MAPKBP1 appears to be a novel microtubule-binding protein with cell cycle dependent centriolar localization. Truncation of its coiled-coil domain is enough to abrogate its dimerization and results in severely disturbed intracellular localizations. Delineating the impact of impaired dimerization on cell cycle regulation and intracellular kidney signaling may provide new insights into common mechanisms of kidney degeneration. Thus, due to milder clinical presentation, MAPKBP1-associated nephronophthisis should be considered in adult patients with otherwise unexplained chronic kidney disease.","dc:creator":"SchÃ¶nauer R","dc:date":"2020","dc:title":"Novel nephronophthisis-associated variants reveal functional importance of MAPKBP1 dimerization for centriolar recruitment."}},"rdfs:label":"Patient 2"},{"id":"cggv:77ff558e-dd5d-4e5a-ba81-21c9997acc35","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:77ff558e-dd5d-4e5a-ba81-21c9997acc35_variant_evidence_item"},{"id":"cggv:77ff558e-dd5d-4e5a-ba81-21c9997acc35_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"HeLa cell analysis indicated atypical localization in mutants. The wild-type localization was centrosomal, centrosomal and filamentous or granular, or mainly granular. Patient mutations had primarily cytosolic localization with/without nuclear localization, and just minuscule co-localization with PCNT. \n"}],"strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:63f98baf-759b-49a4-9aa0-84d62b3b506d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:63f98baf-759b-49a4-9aa0-84d62b3b506d","type":"Proband","ageUnit":"Years","ageValue":15,"allele":{"id":"cggv:c3e9428d-51a6-4ab6-8343-ef3539696fcf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.1300C>T (p.Arg434Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7497796"}},"detectionMethod":"The Authors initially performed homozygosity mapping and whole-exome sequencing (WES) in the proband. The segregation of the identified variants were examined by Sanger sequencing..","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Juvenile nephronophthisis, Renal transplantation (age:15 years), Dilated tubules, thickened basal membrane","phenotypes":["obo:HP_0003774","obo:HP_0001999","obo:HP_0000090","obo:HP_0005576","obo:HP_0000092"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"cggv:d708c2ec-076f-427f-8e8c-b40695007784_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c3e9428d-51a6-4ab6-8343-ef3539696fcf"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28089251"},"rdfs:label":"F1323-21"},{"id":"cggv:d708c2ec-076f-427f-8e8c-b40695007784","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:d708c2ec-076f-427f-8e8c-b40695007784_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downgraded for homozygosity/consanguinity; there is functional evidence, but it is not super specific to the patient's phenotype. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0954d83c-4448-4b06-a1ce-3906bac3b39f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0954d83c-4448-4b06-a1ce-3906bac3b39f","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":23,"allele":{"id":"cggv:f50de20b-d0e8-4dad-9ad7-c571d80d4113","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.1613G>A (p.Arg538Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043974"}},"detectionMethod":"Ciliary exome targeted sequencing and bioinformatics filtering conducted in NPH2139-21 individual was performed using a custom SureSelect capture kits (Agilent Technologies) targeting 4.5 Mb of 20,168 exons (1221 ciliary candidate genes), including MAPKBP1. Methods found in supplemental document, Table S1","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Isolated nephronophthisis, Late onset nephronophthisis, Focal interstitial infiltration, sclerotic glomeruli, thickened capsular basement membrane","phenotypes":["obo:HP_0000090","obo:HP_0005576","obo:HP_0000092","obo:HP_0000095"],"sex":"Male","variant":{"id":"cggv:fadc668d-abf3-4e8b-816c-41adb8817f72_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f50de20b-d0e8-4dad-9ad7-c571d80d4113"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28089251"},"rdfs:label":"NPH2139-22"},{"id":"cggv:fadc668d-abf3-4e8b-816c-41adb8817f72","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:fadc668d-abf3-4e8b-816c-41adb8817f72_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Proband should technically be scored at 0.1 total since this is a homozygous/consanguineous case. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:79fb3426-f8cc-4048-8b0e-b6612afee05e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:79fb3426-f8cc-4048-8b0e-b6612afee05e","type":"Proband","allele":{"id":"cggv:3ab4cac4-6056-456c-a5d3-640b616af568","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.4299+5G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2473134704"}},"detectionMethod":"Exome sequencing, homozygosity mapping, and targeted NGS multi kidney disease gene panel testing were all performed independently on patient samples.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Kidney transplant","phenotypes":["obo:HP_0004719","obo:HP_0000678","obo:HP_0000520","obo:HP_0001999","obo:HP_0000107","obo:HP_0002650","obo:HP_0003774"],"secondTestingMethod":"Homozygosity mapping","sex":"Female","variant":{"id":"cggv:d42a8fc1-48d5-4634-9c7d-4d0ee0baa5c4_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:3ab4cac4-6056-456c-a5d3-640b616af568"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/32505465"},"rdfs:label":"Patient 1"},{"id":"cggv:d42a8fc1-48d5-4634-9c7d-4d0ee0baa5c4","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:d42a8fc1-48d5-4634-9c7d-4d0ee0baa5c4_variant_evidence_item"},{"id":"cggv:d42a8fc1-48d5-4634-9c7d-4d0ee0baa5c4_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"HeLa cell analysis indicated atypical localization in mutants. The WT localization was centrosomal, centrosomal and filamentous or granular, or mainly granular. \nPatient mutations had primarily cytosolic localization with/without nuclear localization and just minuscule co-localization with PCNT. Mid-body localization was also seen. \n"}],"strengthScore":0.25,"dc:description":"Score should technically be 0.6 (0.1 * 2 + 0.4) as this is scored an other variant (truncates protein in last exon, not predicted to undergo nonsense-mediated decay), and there is functional evidence. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:0ab57e15-49c6-4b1a-a44b-684adccc5ea0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:0ab57e15-49c6-4b1a-a44b-684adccc5ea0","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":25,"allele":[{"id":"cggv:bc14b4d9-eddd-46e7-ad57-99307e4212eb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.592C>T (p.Arg198Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043972"}},{"id":"cggv:e4df3322-f784-4ffd-a5cb-a4cc579d72d6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.4375C>T (p.Arg1459Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043973"}}],"detectionMethod":"The Authors initially performed whole-exome sequencing (WES) in the proband. The segregation of the identified variants were examined by Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Late-onset nephronophthisis","phenotypes":["obo:HP_0001833","obo:HP_0003045","obo:HP_0100807","obo:HP_0000090"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"cggv:5b579fa8-6dff-4218-b750-e26d5f9513c3_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:e4df3322-f784-4ffd-a5cb-a4cc579d72d6"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28089251"},{"id":"cggv:b7e0490e-0a98-45ac-b0af-9ae9fd2fddbb_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:bc14b4d9-eddd-46e7-ad57-99307e4212eb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28089251"}],"rdfs:label":"BN-22"},{"id":"cggv:b7e0490e-0a98-45ac-b0af-9ae9fd2fddbb","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:b7e0490e-0a98-45ac-b0af-9ae9fd2fddbb_variant_evidence_item"},{"id":"cggv:b7e0490e-0a98-45ac-b0af-9ae9fd2fddbb_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Localization of MAPKBP1 to mitotic spindle polls was inhibited in patient fibroblasts compared to the control."}],"strengthScore":1.5,"dc:description":"The functional evidence was not used to upgrade the score as it showed that the variant impaired function, and the variant was already scored as a loss-of-function mutation. "},{"id":"cggv:5b579fa8-6dff-4218-b750-e26d5f9513c3","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:5b579fa8-6dff-4218-b750-e26d5f9513c3_variant_evidence_item"},{"id":"cggv:5b579fa8-6dff-4218-b750-e26d5f9513c3_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Localization of MAPKBP1 to mitotic spindle polls is inhibited in patient fibroblasts compared to the control."}],"strengthScore":0.5,"dc:description":"This variant is not predicted to lead to nonsense-mediated decay, as it is in the last exon. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:b32de130-11e3-4a7f-89f0-df06b0d375d4_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:b32de130-11e3-4a7f-89f0-df06b0d375d4","type":"Proband","ageUnit":"Years","ageValue":39,"allele":{"id":"cggv:d6c5a656-7ecc-4cf9-aa5f-089a43d028fb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.2809C>T (p.Gln937Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043976"}},"detectionMethod":"The Authors initially performed homozygosity mapping and whole-exome sequencing (WES) in the proband. The segregation of the identified variants were examined by Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002650","obo:HP_0000090","obo:HP_0003774"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:ef210bca-0a71-4910-976f-01805b972778_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d6c5a656-7ecc-4cf9-aa5f-089a43d028fb"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28089251"},"rdfs:label":"NPH309-21"},{"id":"cggv:ef210bca-0a71-4910-976f-01805b972778","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:ef210bca-0a71-4910-976f-01805b972778_variant_evidence_item"},{"id":"cggv:ef210bca-0a71-4910-976f-01805b972778_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Localization of MAPKBP1 to mitotic spindle polls is inhibited in patient fibroblasts compared to the control. "}],"strengthScore":1,"dc:description":"Downgrading for consanguinity/homozygosity; even though there is functional evidence, it is not super specific to the patient's phenotype"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:5112b58b-2107-46ce-a829-498e7a52938e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:5112b58b-2107-46ce-a829-498e7a52938e","type":"Proband","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":12,"allele":{"id":"cggv:f3cfaef8-99cc-4d00-a3d7-7081f8b50035","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.3314+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA391874415"}},"firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"eGFR at diagnosis: 83.0","phenotypes":["obo:HP_0002900","obo:HP_0000096","obo:HP_0004719","obo:HP_0005932","obo:HP_0005576"],"sex":"Female","variant":{"id":"cggv:8c248ad3-4c4f-43cd-a6fc-d3c46043bdc2_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:f3cfaef8-99cc-4d00-a3d7-7081f8b50035"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/35140360","type":"dc:BibliographicResource","dc:abstract":"Nephronophthisis is an autosomal-recessive kidney disease that is caused by abnormalities in primary cilia. Nephronophthisis-related ciliopathies (NPHP-RCs) are a common cause of end-stage kidney disease (ESKD) in children and adolescents. NPHP-RCs are often accompanied by extrarenal manifestations, including intellectual disability, retinitis pigmentosa, or polydactyly. Although more than 100 causative genes have been identified, its diagnosis is difficult because the clinical features of each mutation often overlap. From September 2010 to August 2021, we performed genetic analysis, including next-generation sequencing (NGS), in 574 probands with kidney dysfunction and retrospectively studied cases genetically diagnosed with NPHP-RCs. RESULTS: We detected mutations related to NPHP-RCs in 93 patients from 83 families. Members of 60 families were diagnosed using NGS, and the mutations and the corresponding number of families are as follows: NPHP1 (24), NPHP3 (10), OFD1 (7), WDR35 (5), SDCCAG8 (4), BBS10 (3), TMEM67 (3), WDR19 (3), BBS1 (2), BBS2 (2), IFT122 (2), IFT140 (2), IQCB1 (2), MKKS (2), SCLT1 (2), TTC21B (2), ALMS1 (1), ANKS6 (1), BBS4 (1), BBS12 (1), CC2D2A (1), DYNC2H1 (1), IFT172 (1), and MAPKBP1 (1). A total of 39 cases (41.9%) progressed to ESKD at the time of genetic analysis, whereas 58 cases (62.3%) showed extrarenal manifestations, the most common being developmental delay, intellectual disability, and autism spectrum disorder in 44 patients. Comprehensive genetic analysis using NGS is useful for diagnosing patients with NPHP-RCs.","dc:creator":"Sakakibara N","dc:date":"2022","dc:title":"Comprehensive genetic analysis using next-generation sequencing for the diagnosis of nephronophthisis-related ciliopathies in the Japanese population."}},"rdfs:label":"New proband (re-curation)"},{"id":"cggv:8c248ad3-4c4f-43cd-a6fc-d3c46043bdc2","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8c248ad3-4c4f-43cd-a6fc-d3c46043bdc2_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a211102c-3eb0-4922-aad9-54a7fb0de70e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a211102c-3eb0-4922-aad9-54a7fb0de70e","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":15,"allele":{"id":"cggv:d6bb8cf0-61d1-4f43-abb3-b0adb7169619","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014994.3(MAPKBP1):c.2426-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043975"}},"detectionMethod":"The Authors initially performed homozygosity mapping and whole-exome sequencing (WES) in the proband. The segregation of the identified variants were examined by Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Late-onset nephronophthisis, Narrowed parenchyma, Massive interstitial fibrosis, Increased renal echogenicity","phenotypes":["obo:HP_0000107","obo:HP_0005576","obo:HP_0000090","obo:HP_0003774","obo:HP_0000092"],"sex":"Female","variant":{"id":"cggv:a6ee268c-217d-4321-b05c-99f8ef6360b1_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d6bb8cf0-61d1-4f43-abb3-b0adb7169619"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/28089251"},"rdfs:label":"A3977-22"},{"id":"cggv:a6ee268c-217d-4321-b05c-99f8ef6360b1","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:a6ee268c-217d-4321-b05c-99f8ef6360b1_variant_evidence_item"},{"id":"cggv:a6ee268c-217d-4321-b05c-99f8ef6360b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Localization of MAPKBP1 to mitotic spindle polls is inhibited in patient fibroblasts compared to control."}],"strengthScore":1,"dc:description":"Downgrading for homozygosity/consanguinity. Even though there is functional evidence, it is not super specific to the proband's phenotype."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8657,"specifiedBy":"GeneValidityCriteria10","strengthScore":13,"subject":{"id":"cggv:db269f2c-8b24-488b-b2a8-8a8a5322e70c","type":"GeneValidityProposition","disease":"obo:MONDO_0014997","gene":"hgnc:29536","modeOfInheritance":"obo:HP_0000007"},"version":"3.0","dc:description":"MAPKBP1 was first reported in relation to autosomal recessive nephronophthisis in 2017 (Maria et al., PMID: 28089251). Ten variants (nonsense, frameshift, missense) that have been reported in 11 probands in 4 publications (PMIDs: 28089251, 32505465, 33623699, 35140360) are included in this curation. All but two of the variants are null, indicating that this disease is largely caused by a loss-of-function mechanism. The maximum score for genetic evidence (12 pts.) was reached. This gene-disease relationship is also supported by experimental evidence (expression-level evidence, functional alteration evidence; PMID: 28089251). Expression analysis showed that the encoded protein is expressed in tubular epithelial cells and glomeruli of the adult kidney. Analysis of inner medullary collecting duct cells shows increased DNA Damage Response signaling in mutants, consistent with the human phenotype. This gene-disease pair was originally evaluated by the ClinGen Kidney Cystic & Ciliopathy GCEP on 5/26/2021, and re-evaluated on 6/10/2024. Even though there was only one new case (PMID: 35140360) and no new experimental evidence, the panel felt that there was ample genetic evidence, with supporting functional evidence for many of the mutations, that outweighed the limited other experimental evidence. As a result of this reevaluation, the classification increased from Strong to Definitive supporting the relationship between MAPKBP1 and autosomal recessive nephronophthisis that has been demonstrated in both the research and clinical diagnostic settings, and upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on the meeting date 6/10/2024 (SOP Version 10).","dc:isVersionOf":{"id":"cggv:b8542450-d48b-45ba-bd5f-4e55d210aa6b"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}